1-3 of 3
Konstantinos Lefkimmiatis, PhD
Close
Sort by
Journal Articles

Human Monoclonal Antibody Targeting IL-17A (AIN457) Down-Regulates MM Cell-Growth and Survival and Inhibits Osteoclast Development In Vitro and In Vivo: A Potential Novel Therapeutic Application In Myeloma

Rao H Prabhala, PH.D., Mariateresa Fulciniti, PhD, Dheeraj Pelluru, PhD, Puru Nanjappa, MS, Christine Pai, BS, Saem Lee, B.A., Nithya Prabhala, Weihua Song, MD, Constantine S. Mitsiades, MD, PhD, Konstantinos Lefkimmiatis, PhD, Yu-Tzu Tai, PhD, Irene Ghobrial, MD, Paul Richardson, MD, John Daley, Kenneth C. Anderson, MD, Seth Ettenberg, Franco Di Padova, Nikhil C. Munshi, MD
Journal: Blood
Blood (2010) 116 (21): 456.
https://doi.org/10.1182/blood.V116.21.456.456
Published: 2010
Journal Articles

Induction of UBC9 and the Sumoylation Pathway in Multiple Myeloma Promotes Plasma Cell Growth and Correlates with Decreased Patient Survival.

James J. Driscoll, MD, PhD, Konstantinos Lefkimmiatis, PhD, Mariateresa Fulciniti, PhD, Rao Prabhala, PhD, Dheeraj Pelluru, PhD, Philip R. Greipp, MD, Nikhil C. Munshi, MD
Journal: Blood
Blood (2007) 110 (11): 3516.
https://doi.org/10.1182/blood.V110.11.3516.3516
Published: 2007
Journal Articles

DNA Damage Induced Sumoylation of p53 in Multiple Myeloma: Implications for Cell Proliferation and Apoptosis.

James J. Driscoll, MD, PhD, Dheeraj Pelluru, PhD, Rao Prabhala, PhD, Konstantinos Lefkimmiatis, PhD, Mariateresa Fulciniti, PhD, Nikhil C. Munshi, MD
Journal: Blood
Blood (2007) 110 (11): 112.
https://doi.org/10.1182/blood.V110.11.112.112
Published: 2007